| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/12/1997 | CA2239868A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 06/12/1997 | CA2239728A1 Live attenuated vaccines based on cp45 hpiv-3 strain and method to ensure attenuation in such vaccines |
| 06/12/1997 | CA2239709A1 Method of diagnosing and treating epithelioma |
| 06/12/1997 | CA2239448A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239226A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2239203A1 Drug therapy |
| 06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
| 06/12/1997 | CA2237495A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | CA2236913A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 06/11/1997 | EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777738A1 Condii toxoplasma p30 expression cassette |
| 06/11/1997 | EP0777733A1 Method of treating birds with avian myelomonocytic growth factor |
| 06/11/1997 | EP0777690A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
| 06/11/1997 | EP0777689A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 06/11/1997 | EP0777688A1 New immunocontraceptive peptides |
| 06/11/1997 | EP0777685A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777499A1 Live vaccine for the treatment of tumour diseases |
| 06/11/1997 | EP0777497A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777490A1 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 06/11/1997 | EP0777474A1 Methods for the treatment of inflammatory joint disease |
| 06/11/1997 | EP0777458A1 Control of hair growth |
| 06/11/1997 | EP0525005B1 Method for inhibiting cell growth and compositions useful therefor |
| 06/11/1997 | EP0472706B1 Induction of protection against viral infection |
| 06/11/1997 | EP0446315B1 Process for the preparation of pai-2 |
| 06/11/1997 | EP0394409B1 Macrophage-derived inflammatory mediator (mip-2) |
| 06/10/1997 | US5637686 Tata-binding protein associated factor, nucleic acids |
| 06/10/1997 | US5637677 Biologically active compounds and methods of constructing and using the same |
| 06/10/1997 | US5637569 Ganglioside analogs |
| 06/10/1997 | US5637493 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 06/10/1997 | US5637487 Genetic engineered polypeptide; used for immunization of chickens against coccidiosis |
| 06/10/1997 | US5637483 Irradiated tumor cell vaccine engineered to express GM-CSF |
| 06/10/1997 | US5637455 HIV-2 virus variants |
| 06/10/1997 | US5637454 Assays and treatments of autoimmune diseases |
| 06/10/1997 | US5637303 Use of a phospholipase D mutant of Corynebacterium pseudotuberculosis for vaccination |
| 06/10/1997 | US5637300 Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception |
| 06/10/1997 | US5637288 Chimeric antibody for detection and therapy of infectious and inflammatory lesions |
| 06/05/1997 | WO1997020063A1 THEREAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8 |
| 06/05/1997 | WO1997020059A1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
| 06/05/1997 | WO1997020054A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 06/05/1997 | WO1997020050A1 Therapeutic and diagnostic compositions |
| 06/05/1997 | WO1997020036A1 Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines |
| 06/05/1997 | WO1997020033A1 Salmonella vaccines |
| 06/05/1997 | WO1997019957A1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
| 06/05/1997 | WO1997019952A1 The ob receptor and methods of diagnosing and treating weight |
| 06/05/1997 | WO1997019698A1 Diphtheria toxin epitopes |
| 06/05/1997 | WO1997019688A1 Non-toxic mutants of pathogenic gram-negative bacteria |
| 06/05/1997 | WO1997017444A3 Novel sperm receptors |
| 06/05/1997 | WO1997013858A3 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use |
| 06/05/1997 | WO1996039113A3 Oral administration of pneumococcal antigens |
| 06/05/1997 | DE19611235C1 Increased yield of antibodies in humans and animals by injection of antigens |
| 06/05/1997 | CA2239012A1 Diphtheria toxin epitopes |
| 06/05/1997 | CA2238569A1 The ob receptor and methods of diagnosing and treating weight |
| 06/05/1997 | CA2236574A1 Therapeutic and diagnostic compositions |
| 06/04/1997 | EP0776906A2 Sm-D peptide antigens and their use especially in the diagnosis of systemic lupus erythromatodes |
| 06/04/1997 | EP0776366A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 06/04/1997 | EP0776362A1 Method for preparing an influenza virus, antigens obtained and applications thereof |
| 06/04/1997 | EP0776361A1 Recombinant herpesvirus of turkeys and uses thereof |
| 06/04/1997 | EP0776339A1 Mhc complexes and uses thereof |
| 06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
| 06/04/1997 | EP0776336A1 Vitronectin binding protein |
| 06/04/1997 | EP0776217A1 A method of treating a patient with a biologically active compound |
| 06/04/1997 | EP0776216A1 Dual carrier immunogenic construct |
| 06/04/1997 | EP0776215A1 Device for delivery of substances and methods of use thereof |
| 06/04/1997 | EP0776209A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 06/04/1997 | CN1151185A Nucleotide sequences of pestivirus strains, polypeptides encoded by these squences and use thereof for diagnosis and prevention of pestivirus infections |
| 06/04/1997 | CN1151167A Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 06/04/1997 | CN1151120A Method and compositions useful for inhibition of angiogenesis |
| 06/04/1997 | CN1151119A Medical use of bromelain |
| 06/03/1997 | US5635617 Methods and compositions comprising the agfA gene for detection of Salmonella |
| 06/03/1997 | US5635603 Antibody fragment covalently bound to diagnostic or therapeutic principle through carbohydrate moiety |
| 06/03/1997 | US5635601 Beta-8 integrin subunit antibodies |
| 06/03/1997 | US5635388 Monoclonal antibody produced by a hybridoma cell binds to the extracellular domain of flk2/flk3 and activates the intracellular tyrosine kinase domain enhancing repopulation of myeloid and lymphoid blood cell lineages with cytokines |
| 06/03/1997 | US5635374 Bone calcification factor and recombinant production of the factor nucleic acid encoding |
| 06/03/1997 | US5635346 Diagnosing using novel peptide fragments derived from antigens reactive to antibodies present in infected patients |
| 06/03/1997 | US5635188 Serum-free melanoma vaccine obtained by culturing shed human melanoma cell surface antigens |
| 06/03/1997 | US5635182 Method of detecting ligand interactions |
| 06/03/1997 | US5635181 Pure immunogenic peptide encoded by dna sequence present in specified recombinant bacterial plasmid |
| 06/03/1997 | US5635177 Useful in enabling role of tyrosine kinase receptor in cell growth and differentiation |
| 06/03/1997 | CA2077651C Peptides stimulating cytotoxic t cells immune to hiv rt |
| 06/02/1997 | CA2164274A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 05/29/1997 | WO1997019174A1 Virus protein antigens of the jc virus |
| 05/29/1997 | WO1997019169A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | WO1997019113A2 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 05/29/1997 | WO1997019111A2 Monoclonal antibodies anti-cd6 and their uses |
| 05/29/1997 | WO1997019107A1 Identification of antigenes from post-infection nematodes for the purpose of developing new anthelmintics and vaccines |
| 05/29/1997 | WO1997019098A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics |
| 05/29/1997 | WO1997018841A1 Non-invasive localization of a light-emitting conjugate in a mammal |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | WO1997018805A1 Combinational therapeutic methods employing nitric oxide scavengers |
| 05/29/1997 | WO1997018799A1 Use of a tnf alpha antagonist for treating neurogenic skin redness |
| 05/29/1997 | WO1997018790A2 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 05/29/1997 | WO1997005899A3 Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same |
| 05/29/1997 | WO1996036713A3 Eck receptor ligands |
| 05/29/1997 | CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238262A1 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 05/29/1997 | CA2238176A1 Tumour vaccine and process for the preparation thereof |